Sunday , April 22 2018
Home / Therapies / Insulin Therapy Center (page 9)

Insulin Therapy Center

Insulin Therapy for Diabetes: Diabetes in Control answers key questions about the uses and challenges of insulin in diabetes management, including:
– How insulin is used to treat diabetes
– How/when a healthcare professional should consider insulin therapy for diabetes patients
– What a healthcare professional needs to know about making insulin therapy safe and effective

How Long Does the Insulin Last? Do The Math!

In assessing an in-patient's diabetic educational needs, I was reviewing with him his in-home regimen for his insulin therapy. Per his report, he stated that he took Levemir 50 units twice a day. I asked if it was by needle, syringe and vial preparation, which it was. I instructed him re: the shelf life of Levemir of 42 days once opened. He stated, "I throw it out after a month, but there is always insulin in the vial.” He also said he has more than an adequate supply. He was receiving his insulin by mail-order, receiving as he should, but not using it in a timely fashion. In other words, he was stockpiling his insulin.

Read More »

Lowering Carbs Can Be Helpful Tool in Weight Loss for People with Insulin-Requiring Diabetes

Female, 28 years of age, diagnosed with type 1 diabetes at age 25. She was taught to manage her diabetes with a basal/bolus insulin regimen and meal plan prescribed by health care team. She was taught she could eat anything she wanted as long as she covered her carbs with rapid-acting insulin. Her glucose was in control, but she gained 50 pounds over the first year. She then attributed her weight gain to taking insulin, so she would not take enough insulin to cover her glucose levels.

Read More »

Dr. Richard Bergman, Part 1 – Measuring Insulin Resistance

Diabetes in Control Publisher Steve Freed meets with Dr. Richard Bergman at the 75th ADA Scientific Sessions in Boston. In this first installment, Dr. Bergman shares his start in diabetes research and explains the high points of his presentation, Comparative Methods for Assessment of Insulin Sensitivity: Oral Vs. Intravenous. Dr. Richard Bergman is the founder and director of Diabetes and Obesity Research Institute, Biomedical Sciences at Cedars-Sinai in Los Angeles. He introduced the use of engineering principles to understand the pathogenesis of diabetes.

Read More »

Know Your Pen Needles

In a follow-up visit for an insulin-requiring patient with type 2 DM, it was obvious that the management of his DM had deteriorated. According to his girlfriend, this patient ate only 1-2 meals a day, but they tended to be high-carbohydrate meals. We reviewed the patient's insulin regimem in detail and ascertained that he was using the sliding scale correctly.

Read More »